DUSSELDORF, Germany, July 1 /PRNewswire/ -- Gerresheimer AG, a leading manufacturer of glass and plastic products for the pharma life science industry, has sold its Technical Plastics operations, which are not part of the MDAX company's core business, to the FBH Group, Bad Soden, Germany. Through the sale of the Technical Plastics segment Gerresheimer has - as formerly announced - taken a further step in its focus on the core business of pharma life science, says Dr. Axel Herberg, CEO of Gerresheimer AG.
The Technical Plastics business has so far been part of Gerresheimer Wilden GmbH. Complex injection-molded plastic components for the automobile industry are manufactured by around 430 employees at plants in Germany, the Czech Republic and Mexico. Sales by this business, including the tool business which is also being sold, totaled EUR74m in the financial year 2008.
The purchaser is a company in the FBH Group, Bad Soden, to which Thermoplast Technik Beteiligungs-AG, a medium-sized manufacturer of injection-molded parts, belongs. Components for the automobile industry are manufactured in five production plants. Through the sale, FBH will expand its plant network and existing product range.
The purchase price including the debts taken over amounts to EUR12m. The transfer takes place with effect from July 1, 2009.
Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.
Contact Press Burkhard Lingenberg Director Corporate Communication Marketing Phone +49-211-6181-250 Fax +49-211-6181-241 e-mail email@example.com Contact Investor Relations Anke Linnartz Director Corporate Investor Relations Phone +49-211-6181-314 Fax +49-211-6181-121 e-mail firstname.lastname@example.org
Contact Press, Burkhard Lingenberg, Director Corporate Communication Marketing, Phone +49-211-6181-250, Fax +49-211-6181-241, e-mail email@example.com; Contact Investor Relations, Anke Linnartz, Director Corporate Investor Relations, Phone +49-211-6181-314, Fax +49-211-6181-121, e-mail firstname.lastname@example.org